Skip to main content
Clinical Trials/IRCT20170315033086N6
IRCT20170315033086N6
Completed
Phase 2

The efficacy of Inflawell capsules containing Boswellic acids in patients with cognitive impairment due to traumatic brain injury: A Randomized, Double-blind Placebo-controlled Trial

Tehran University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
100
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • traumatic brain injury patients
  • Patients who are in 3 months to 3 years from the time of traumatic brain injury

Exclusion Criteria

  • Patients with uncontrollable seizures
  • Patients with impaired level of consciousness
  • Patients with (Glasgo outcome scale) GOS less than 3
  • Taking anticholinergic drugs
  • Taking anticonvulsants and sedatives drugs (such as Phenytoin, Topiramate, Levetiracetam)
  • Epidural hematoma, subdural hematoma and Contusion
  • substance abuse
  • Previous brain trauma
  • Multiple sclerosis, Bipolar mood disorder, Schizophrenia, aphasia, spinal cord injury, motor disorder
  • Lactation and pregnanacy

Outcomes

Primary Outcomes

Not specified

Similar Trials